PhD Andrés WigdorovitzWorkshopArgentina -Japan3 rd August 2009
Institute of Virology and Institute of Genetic CICVyA, INTA, Castelar, Argentina
Institute of Genetic and Molecular Biology INGEBI, Buenos Aires, Argentina
Workshop Argentina-Japan“Bioscience and Biotechnology for the Promotion
for Agriculture and Food Production”August 3rd to 7th, 2009
Veterinary vaccines produced in plants
Summary
Production of nanobodies (Llama –derived Single –Chain Antibody Fragments), in tobacco transplantomic plants.
Production of experimental vaccines in alfalfa transgenic plants
Foot and mouse disease virus
Development of transgenic alfalfa plants containing the foot and mouth disease virus structural polyprotein P1 and its utilization as an experimental immunogen.
Bovine diarrhea virus First report of an experimental vaccine against BVDV produced in alfalfa transgenic plants that induce neutralizing antibodies and protection in cattle.
Bovine RotavirusPassive protection against bovine rotavirus (BRV) induced by a peptide edible vaccine produced in transgenic alfalfa.
Agriculture and Food Production in Argentina
WorkshopArgentina -Japan3 rd August 2009
ARGENTINAARGENTINA
•• 3,760,000 km3,760,000 km22
•• Population~ 39 M Population~ 39 M
•• GovernmentGovernment::
RepresentativeRepresentative
RepublicanRepublican
FederalFederal
•• LanguageLanguage
SpanishSpanish
NOA• Sugar
• Tobacco
• Citrus
• Oilseeds: Soybean, Olive
• Wine
• Bovine Meat
• Vegetables
• Native Forest
• Honey
• Camelids
• Cotton
NEA• Bovine Meat
• Cotton
• Oilseed: Soybean
• Implanted Forest
• Native Forest
• Yerba Mate (Ilexparaguaiensis)
• Tea
• Rice
• Citrus
• Vegetables
• TobaccoCUYO• Pip Fruit
• Wine
• Oilseed: Olive
• Vegetables
• Bovine Meat
PATAGONIA• Wool
• Ovine Meat
• Apple and Pear
• Berries
• Native Forest
• Bovine Meat
• Wine
• Honey
PAMPEANA• Wheat and Maize
• Oilseeds: Soybean-Sunflower
• Bovine Meat
• Bovine Milk
• Vegetables
• Porcine Meat
• Fruits
• Rice
• Poultry and Eggs
• Implanted Forest
ARGENTINE PRODUCTIONARGENTINE PRODUCTION
AGRICULTURAL PRODUCTIONAGRICULTURAL PRODUCTION
Grains:Grains: 41,912 million tons41,912 million tons
Oilseeds:Oilseeds: 51,502 million tons51,502 million tons
Pip fruit: Pip fruit: 1,936 million tons1,936 million tons
Citrus: Citrus: 3,091 million tons3,091 million tons
Honey: Honey: 115,000 tons115,000 tons
Wines: Wines: 15,400 million hectoliters15,400 million hectoliters
Beef: Beef: 3,117 million tons3,117 million tons
Pork: Pork: 198,050 tons198,050 tons
Poultry: Poultry: 1,160,000 tons1,160,000 tons
Milk: Milk: 9.600 million liters9.600 million liters
Wool:Wool: 76.500 tons76.500 tons
AGRICULTURAL EXPORTSAGRICULTURAL EXPORTS
Agricultural and livestock exports: 23.870 million USDAgricultural and livestock exports: 23.870 million USD
•• First world exporter of flour and oil soybean, First world exporter of flour and oil soybean, sunflower oil, honey, pears and lemon.sunflower oil, honey, pears and lemon.
•• Second world exporter of maize and sorghum.Second world exporter of maize and sorghum.
•• Third world exporter of soybean.Third world exporter of soybean.
•• Fifth world exporter of wheat and beef.Fifth world exporter of wheat and beef.
Gross Domestic Product: 213.172 million USDGross Domestic Product: 213.172 million USD
Agricultural, Livestock and AgroAgricultural, Livestock and Agro--industry GDP: industry GDP: 30%30%
INTA INTA HeadquartersHeadquarters15 Regional 15 Regional CentersCenters4747 Experimental StationsExperimental Stations4 4 ResearchResearch CentersCenters15 15 Research Institutes Research Institutes > 300> 300 Extension Agencies Extension Agencies
2 2 PrivatePrivate OrganizationsOrganizations
Alfalfa (Medicago sativa)
It is the most important forage grass in Argentine and it presents high levels of total soluble protein.
General plant advantages :
Economic.
Easy to obtain in big amounts.
It can be used as an oral vaccine.
General plants disadvantages:Low levels of heterologue protein
expression.
Production of experimental vaccines in alfalfa transgenic plants
Introduction FOOT AND MOUTH DISEASE VIRUS
FMDV is a picornavirus with a single-stranded positive sense RNA genome.
Icosaedrical capsid, 30nm size
4 structural proteins compose its capsid:VP1, VP2, VP3 and VP4.
It is responsable for the most important economiclosses of cattle production in the world
ObjectivesExpression of P1 polyprotein of Foot and Mouth Diseasevirus in transgenic alfalfa plants for the production ofexperimental vaccines.
Evaluation in a murine model.
Construction # transformed plants
pROK-P1.2A.2B.3C 20
Electronicmicroscopy
Plant A
FMDV empty capsid
Non Related gene
30 nm
Plant A
30 nm
Detection of neutralizing antibodies induced in I.P immunized mice with plant A extractsNeutralizing
assayMice IP immunized with:
Mouse Nº* SNI
Alfalfa Plant A 1 2.2
2 2.3
3 2.1
4 2.1
Alfalfa expressing a non related gene
5 0.6
6 0.6
Antibody
responseVP1 epitope
0
0,5
1
1,5
2
2,5
3
1 2 3 4 5 6 7 8 9 10 11 12 13Mouse Nº
Tit
er
(lo
g1
0)
ELISA
0,05- 0,2 mg/g TSP
Immune response in mice I.P. immunized with P1
polyprotein transgenic alfalfa plants
Complete FMDV particle
Murine model Protection against FMDV challenge in miceimmunized with P1 polyprotein transgenic plants
Mice IP immunized with:
Protection (%)
Alfalfa Plant A 13/13 (100%) 9/9 (100%)
Alfalfa expressing a non related gene
0/10 (0%) 0/6 (0%)
Buffer 0/6 (0%) 0/6 (0%)
pending patent P040102842
Introduction BOVINE ROTAVIRUS
BRV is a rotavirus with a RNA positive genome.
2 structural proteins compose its outer capsid: VP4, and VP7.
VP4 and VP7 carry critical epitopes responsible for the induction of neutralizing antibodies.
VP 6
VP 7
VP 4
Rotavirus infections are the primary cause of severe diarrhea in young animals and children in the world.
Objective To develop an experimental edible vaccine based on the use of recombinant BRV peptide fused to the enzyme β-GUS expressed in transgenic alfalfa plants.
To assess the ability of the chimerical protein to induce passive protective immunity against virulent bovine rotavirus in suckling mice.
BRV C486 oral infection
weeks42 6 750
copulatenew born
85
Presence ofdiarrhea
Experimental Vaccine
Murine model
Antibody
response
Immune response in mice intraperitoneally immunized with
eBRVP4-BGUS leaves extracts
0,000
0,200
0,400
0,600
0,800
1,000
1,200
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20mice
Abs
490n
m
Immune response in mice fed with eBRVP4-BGUS fresh
leaves
vaccinated dams
respective offspring
Negative control dams
0,000
0,200
0,400
0,600
0,800
1,000
1,200
1,400
1,600
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
mice
Abs
490
nm
ELISA
Mice IP immunizedwith:
Route ofimmunization
Protection (%) Fisher´sTest
Alfalfa expressingeBRV4-βGUS
Oral 22/29 (76%) p=0.003
IP 10/14 (71%) P= 0.0063
Alfalfa expressinga non related gene
oral 4/19 (21%) p=0.003
IP 2/13 (21%) P= 0.0063
Murine model Evaluation of passive protection against BRV C486
Introduction I
BVDV is a pestivirus with a RNA positive genome.
Spherical shape 40 -60 nanometers (nm) of diameter, icosaedral capsid and external envelope.
E2 glycoprotein carries critical epitopes responsible for the induction of neutralizing antibodies.
BOVINE DIARREA VIRUS
Infects bovines of all ages, causing reproduction problems and altering biological products of high commercial value thereby, resulting in considerableeconomical losses.
Plantsexpression I
Quantification and stability of the selected Transgenic plants obtained using Agrobacterium tumefaciens -
mediated transformation of alfalfa
00,20,40,60,8
11,21,41,61,8
2
P1 P2 P3 P4 P5 P6 P7 P8 P9 P10 P11 P12 P13 P14 P15 P16 P17 P18 P19 P20 P21 P22 P23 P24 P1 P2 P3 P4 P5 P6 P7 P8 P9 P10 P11 P12 P13 P14 P15 P16 P17 P18 P19 P20 P21 P22 P23 P24 C+ C+ C- C-
Abs
orva
ncia
405
nm
E2T: 1.7 ugr /gr leafE2: 1,5 ugr/ gr leaf
0
0,5
1
1,5
2
2,5
alfalfa E2T alfalfa E2 alfalfa C23selected plants
Abs
490
nm
3.0 0.4 0.05ugr E2T /ml
Plantsexpression I
Aqueous twoAqueous two--phase systems for purification of phase systems for purification of recombinant E2T and APCH1recombinant E2T and APCH1--E2T proteins expressed in E2T proteins expressed in
alfalfa plantsalfalfa plants
0,428
2
0,00189 0,00121
0,314
3,25
0
0,5
1
1,5
2
2,5
3
3,5
ug/m
l
Ext Planta
ATPS
CHO-K1 SD
ProtPurif 2 ug/ml
Lac Z (C-)
C23 (C-)
y = 0,558x - 1,0059R2 = 0,9919
-1
-0,8
-0,6
-0,4
-0,2
0
0,2
0,4
0 0,5 1 1,5 2 2,5
0,428
2
0,00189 0,00121
0,314
3,25
0
0,5
1
1,5
2
2,5
3
3,5
ug/m
l
Planta ext
ATPS
CHO-K1
Purified prot 2 ug/ml
Lac Z (C-)
C23 (C-)
Curve patron for E2T quantification
y = 0,558x - 1,0059R2 = 0,9919
-1
-0,8
-0,6
-0,4
-0,2
0
0,2
0,4
0 0,5 1 1,5 2 2,5
Evaluation of the immunogenicity of the E2T protein expressed in alfalfa plants in cattle
Antibody
Response I
42 60
weeks
Experimental Vaccine
8
Challenge
3 ug3Negativecontrol (C23-VP8)4
-3BVDV INTA 107/ml3
1,5 ugr3E2T cc alfalfa2
3 ug3E2T cc alfalfa 1
CATTLE DOSISnANTIGENGROUP
3 ug3Negativecontrol (C23-VP8)4
-3BVDV INTA 107/ml3
1,5 ugr3E2T cc alfalfa2
3 ug3E2T cc alfalfa 1
CATTLE DOSISnANTIGENGROUP
Evaluation of the immunogenicity of the E2T protein expressed in alfalfa plants in cattle
Antibody
Response I
Viral neutralizationtest
0
0,5
1
1,5
2
2,5
3
3,5
3 ugr 1.5 ugr control (-) Com. 1 Fortdoge INTA
Títu
lo A
N
T0
30dpv
60dpv
Challenge I Evaluation of the protection induced by the experimental vaccines in cattle
We have the approbation from CONABIA and SENASA for the immunization and challenge experience.
Six-month–old Hereford calves were challenge two weeks after the last
immunization with 25 ml 1 X 10 -6 TCID 50/ml BVDV 98/124 type 1 by aerosolization
* Virus isolation from either plasma or buffy coat. DPI: Days Post-Infection.
0/31/32/33/30/3Ctrl
1/30/30/30/30/3BVDV Inact. (106.5)
0/31/31/30/30/3Alfalfa E2t 1.5 ug
0/30/30/30/30/3Alfalfa E2t 3 ug
0/31/31/32/3*0/3mammalianE2t 1,5 ug
DPI 11DPI 8DPI 6DPI 4DPI 0
Antigen
Viirus shedding after BVDV challenge
Challenge IEvaluation of the protection induced by the experimental vaccines in cattle
pending patent P 090100556
To express a fusion protein between a Single Chain Antibody Fragment (APCH1) against MHC class II using Cassava promoter, in order to optimize the accessibility of the recombinant protein to the immune system
Objective II
Agreement ALGENEX – INTA.
PCT/ES2008/070053. Pending patent P080101073
Vaccine antigen
Plantsexpression II
Transgenic plants obtained using Agrobacteriumtumefaciens - mediated transformation of alfalfa
Construction # transformed plants
33
pCar (cassava) –E2t
pCar (cassava) APCH1–E2t
pCar (cassava) –E2
9
12
APCH1 E2T and E2T: 1.7 ugr /gr leafE2: 1,5 ugr/ gr leaf
3,0 0,4 0,05
ugr/ ml E2T
0
0,5
1
1,5
2
2,5
3
alfalfa ScFvE2T
alfalfa E2T alfalfa E2 alfalfa C23
selected plants
Abs
490
nm
Alfalfa APCH1
0
10
20
30
40
50
60
70
80
90
100
Bovine pig horse Sheep Guinea pig
Pos
itive
cel
ls(%
)
Control (-) E2T APCH1-E2T
Binding of APCH1-E2T to MHCII surface of peripheral blood mononuclear cells (PBMCs) from different species
by flow cytometry
Flow cytometry
Booster Week 4 (dilution 1/40)
ELISA
Antibody
Response II
Comparison of the immunogenicity of the E2T and APCH1-E2T protein expressed in alfalfa plants in cattle
Dosis 1 ug
0
0,1
0,2
0,3
0,4
0,5
0,6
0,7
0,8
0,9
0 1 2 3 4 5 6 7
E2T ScFv-E2T
Booster week 4 (dilución 1/40)
Dosis 0.2 ug
0
0,2
0,4
0,6
0,8
1
1,2
1,4
1,6
0 1 2 3 4 5 6 7Semana
OD
(4
05 n
m)
E2T APCH1-E2T
34
33
32
ug31
CATTLE DOSISnANTIGENGROUP
0,2 ug34
0,2 ug33
1 ug3APCH1- E2T 2
1 ug3E2T 1
CATTLE DOSISnANTIGENGROUP
E2T
APCH1- E2T
Negative control 5 1 ug
APCH1-E2T
3
E2T APCH1-E2T
Cattle number
0
0,5
1
1,5
2
2,5
3
3,5
E2T (527) E2T (632) E2T (644) APCH1-E2T
(563)
APCH1-E2T
(567)
APCH1-E2T
(587)
Tit
er
Elisa titer
NA titer
Comparison of the immunogenicity of 0,2 ug of E2T and APCH1 E2T protein expressed in alfalfa plants in cattle
Antibody
Response II
It was possible to express E2T and APCH1-E2T protein in alfalfa transgenic plants
Conclusions
APCH1-E2T recognize the MHCII molecule on the surface ofperipheral blood mononuclear cells (PBMCs) from differentspecies
Without any concentration steps we obtain 1,5 mgr/ kgr of E2t in alfalfa plants
E2t experimental vaccine induce neutralizing antibodies and protection in cattle
APCH1 E2T optimize the immune response in cattle
Results obtained allow us to establish the conditions for recuperation of both protein E2T and APCH1-E2T with high yield, low cost and the possibility to carry out the scale-up easily.
• Small sice molecule (15KDa)
• simple structure
• High thermic and chemic resistance
• Recombinant monoclonal antibodies
VHH: VHH: Fragment corresponding to a variable portion of light chain Fragment corresponding to a variable portion of light chain from from camelidaecamelidae
CH2
CH3
VHHVHHTECNOLOGYTECNOLOGY
Production of nanobodies, in tobacco transplantomic plants.
VHHVHH TECNOLOGYTECNOLOGY
MONOMERIC VHH ANTIBODIES AGAINST ROTAVIRUS VP6 FORVIRUS DETECTION AND PASSIVE PROTECTION
Production of antigens and antibodies for veterinary applications in tobacco transplastomic plants.
Construction pBSW5’UTR / βGUS-E-VHH
Production of antigens and antibodies for veterinary applications in tobacco transplastomic plants.
PhD Andres Wigdorovitz
Maria José Dus Santos PhD
Pecora Andrea
Cristina Gómez
Pérez Aguirreburualde Maria Sol
Fernando Ardila, PhD IGEAF INTA
José Angel Escribano, PhD, ALGENEXINIA
Fernando Bravo Almonacid, PhDCONICET, INGEBI
Mozgovoj Marina PhD
Our Group Our Collaborators
Viviana Viviana ParreParreññoo
Fernando FernandezFernando Fernandez
Top Related